<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087305</url>
  </required_header>
  <id_info>
    <org_study_id>1703M10502</org_study_id>
    <nct_id>NCT03087305</nct_id>
  </id_info>
  <brief_title>Incidence of SCLN Metastasis in Patients Referred for EBUS-TBNA</brief_title>
  <official_title>Incidence of Supraclavicular Lymph Node Metastasis in Patients Referred for EBUS-TBNA for Presumed Primary Lung Cancer by Interventional Pulmonologists.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the anatomic extent of a primary lung cancer and presence of metastasis are
      essential for selection of an appropriate management strategy. Endobronchial ultrasound
      transbronchial needle aspiration (EBUS-TBNA) is a reliable and established technique to
      evaluate involvement of mediastinal lymph nodes (LN); however, it is an invasive procedure
      and may not be tolerated in patients with severe underlying lung disease. One exception is
      the superficially located supraclavicular lymph nodes (SCLN), which can easily be biopsied
      with percutaneous US-guided-fine needle aspiration (US-FNA). Traditionally, this nodal group
      is evaluated by palpation; however, literature suggests that palpation itself fails to
      capture 66% of proven disease by cytology, which challenges the acceptance that non-palpable
      nodes are indicative of absent disease. Since all palpable SCLN are biopsied to rule out
      metastasis, we may potentially up-stage more patients using ultrasound evaluation for
      non-palpable nodes; and offer more appropriate management. Currently, the incidence for
      non-palpable SCLN metastasis has not been defined in this patient population presenting for
      EBUS-TBNA. The primary objective is to determine the incidence of supraclavicular lymph node
      metastasis by ultrasound evaluation in patients referred for EBUS-TBNA.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    low enrollment rate
  </why_stopped>
  <start_date type="Anticipated">May 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of supraclavicular metastasis</measure>
    <time_frame>7 days</time_frame>
    <description>Incidence of supraclavicular metastasis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>All patients age 20yrs or greater referred for EBUS-TBNA with suspicion for primary lung cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Supraclavicular lymph node ultrasound</intervention_name>
    <description>Patients will have supraclavicular lymph node assessed prior to EBUS-TBNA</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients age 20yrs or greater referred for EBUS-TBNA with suspicion for primary lung
        cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients age 20yrs or greater referred for EBUS-TBNA with suspicion for primary
             lung cancer

        Exclusion Criteria:

          1. Refusal to sign consent

          2. Signs of skin infection along the neck

          3. Adults who lack the capacity to sign consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Karsell PR, McDougall JC. Diagnostic tests for lung cancer. Mayo Clin Proc. 1993 Mar;68(3):288-96. Review.</citation>
    <PMID>8474273</PMID>
  </reference>
  <reference>
    <citation>Baatenburg de Jong RJ, Rongen RJ, Laméris JS, Harthoorn M, Verwoerd CD, Knegt P. Metastatic neck disease. Palpation vs ultrasound examination. Arch Otolaryngol Head Neck Surg. 1989 Jun;115(6):689-90.</citation>
    <PMID>2655666</PMID>
  </reference>
  <reference>
    <citation>Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000 Mar;174(3):837-44.</citation>
    <PMID>10701636</PMID>
  </reference>
  <reference>
    <citation>Tsunodo-Shimizu H, Saida Y. Ultrasonographic visibility of supraclavicular lymph nodes in normal subjects. J Ultrasound Med. 1997 Jul;16(7):481-3.</citation>
    <PMID>9315199</PMID>
  </reference>
  <reference>
    <citation>Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology. 1992 Apr;183(1):215-20.</citation>
    <PMID>1549675</PMID>
  </reference>
  <reference>
    <citation>Brantigan JW, Brantigan CO, Brantigan OC. Biopsy of nonpalpable scalene lymph nodes in carcinoma of the lung. Am Rev Respir Dis. 1973 Jun;107(6):962-74.</citation>
    <PMID>4712440</PMID>
  </reference>
  <reference>
    <citation>van Overhagen H, Brakel K, Heijenbrok MW, van Kasteren JH, van de Moosdijk CN, Roldaan AC, van Gils AP, Hansen BE. Metastases in supraclavicular lymph nodes in lung cancer: assessment with palpation, US, and CT. Radiology. 2004 Jul;232(1):75-80. Epub 2004 May 27.</citation>
    <PMID>15166326</PMID>
  </reference>
  <reference>
    <citation>Kumaran M, Benamore RE, Vaidhyanath R, Muller S, Richards CJ, Peake MD, Entwisle JJ. Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer. Thorax. 2005 Mar;60(3):229-33.</citation>
    <PMID>15741441</PMID>
  </reference>
  <reference>
    <citation>Kendirlinan R, Ozkan G, Bayram M, Bakan ND, Tutar M, Gür A, Camsari G. Ultrasound guided fine-needle aspiration biopsy of metastases in nonpalpable supraclavicular lymph nodes in lung cancer patients. Multidiscip Respir Med. 2011 Aug 31;6(4):220-5. doi: 10.1186/2049-6958-6-4-220.</citation>
    <PMID>22958429</PMID>
  </reference>
  <reference>
    <citation>Chang DB, Yang PC, Yu CJ, Kuo SH, Lee YC, Luh KT. Ultrasonography and ultrasonographically guided fine-needle aspiration biopsy of impalpable cervical lymph nodes in patients with non-small cell lung cancer. Cancer. 1992 Sep 1;70(5):1111-4.</citation>
    <PMID>1325269</PMID>
  </reference>
  <reference>
    <citation>Fultz PJ, Feins RH, Strang JG, Wandtke JC, Johnstone DW, Watson TJ, Gottlieb RH, Voci SL, Rubens DJ. Detection and diagnosis of nonpalpable supraclavicular lymph nodes in lung cancer at CT and US. Radiology. 2002 Jan;222(1):245-51.</citation>
    <PMID>11756733</PMID>
  </reference>
  <reference>
    <citation>Lee JD, Ginsberg RJ. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Ann Thorac Surg. 1996 Aug;62(2):338-41.</citation>
    <PMID>8694587</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interventional Pulmonary</keyword>
  <keyword>EBUS-TBNA</keyword>
  <keyword>Lung cancer staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

